Skip to main content
SpringerLink
Log in
Book cover

Antibodies

Volume 2: Novel Technologies and Therapeutic Use

  • Book
  • © 2004

Overview

Editors:
  1. G. Subramanian

    1. Littlebourne, Kent, UK

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (12 chapters)

  1. Front Matter

    Pages i-xvi
    Download chapter PDF

  2. Transgenic Technology for Monoclonal Antibody Production

    • Steve Sensoli
    Pages 1-11

  3. Generation, Engineering and Production of Human Antibodies Using Hucal®

    • Ralf Ostendorp, Christian Frisch, Margit Urban
    Pages 13-52

  4. Achieving Appropriate Glycosylation During the Scaleup of Antibody Production

    • X. K. Deng, T. Shantha Raju, K. John Morrow Jr
    Pages 53-78

  5. Approaches to Devise Antibody Purification Processes by Chromatography

    • Egisto Boschetti
    Pages 79-103

  6. Novel Hiv Neutralizing Antibodies Selected from Phage Display Libraries

    • Maxime Moulard, Mei-Yun Zhang, Dimiter S. Dimitrov
    Pages 105-117

  7. Monoclonal and Bispecific Antibodies in Combination with Radiotherapy for Cancer Treatment

    • David Azria, Christel Larbouret, Bruno Robert, Mahmut Ozsahin, Jean-Bernard Dubois, André Pèlegrin
    Pages 119-139

  8. Antibodies, a Potent Tool to Target Genes into Designated Cells and Tissues

    • Francois Hirsch, Olivier Deas, Gabrielle Carvalho, Antoine Dürrbach, Dominique Thierry, Alain Chapel
    Pages 141-155

  9. Intrabodies: Development and Application in Functional Genomics and Therapy

    • Alcide Barberis, Adrian Auf Der Maur, Kathrin Tissot, Peter Lichtlen
    Pages 157-168

  10. Expression of Recombinant Antibodies by Tumour Cells: On Road to Anti-Tumour Therapy

    • Emmanuelle Bonnin, Jean-Luc Teillaud
    Pages 169-182

  11. Antitumor Antibodies: From Research to Clinic

    • Sylvie Ménard, Serenella M. Pupa, Manuela Campiglio, Elda Tagliabue
    Pages 183-187

  12. Macrophages for Immunotherapy

    • Delphine Loirat, Sylvie Jacod, Aurélie Boyer, Fabrice Auzelle, Andrès McAllister, Jean-Pierre Abastado et al.
    Pages 189-197

  13. Future Prospects in Antibody Engineering and Therapy

    • Sophie Siberil, Jean-Luc Teillaud
    Pages 199-215

  14. Back Matter

    Pages 217-232
    Download chapter PDF
Back to top

Keywords

About this book

It is now over one hundred years since von Behring and Kitsato first concluded experiments that led to the use of passive immunisation, employing antibodies raised in animals against tetanus and diphtheria toxins. The advancement of technology both in manufacturing purity product in a cost effective way and the clinical research has proved that antibodies are one ofthe most successful products in biotechnology. Monoclonal antibodies account for between one-third and one-halfof all pharmaceutical products in development and human clinical trials. Both the nature of monoclonal antibody therapies and the relatively large size of the monoclonal antibody dictate the production requirements, for many ofthese therapeutics the monoclonal antibody product will be 100 kilogrammes or more per year. It is widely acknowledged that there is currently a worldwide shortage of biomanufacturing capacity, and the active pharmaceutical ingredient material requirements for these products are expected to increase. Thus the industry is looking for new sources and extensive studies are being carried out not only for alternative technology to meet the needs but also to reveal the new therapeutic applicationsofantibodies. This book brings to the forefront current advances in novel technologies for the manufacturing of monoclonal antibodies and also their extensive clinical importance. The first four chapters give an overview of the new technologies and the successful application in the manufacture of monoclonal antibodies with clinical purity. The next chapters address the application of antibodies in cancer therapy and functional genomic therapy.

Editors and Affiliations

  • Littlebourne, Kent, UK

    G. Subramanian

Bibliographic Information

  • Book Title: Antibodies

  • Book Subtitle: Volume 2: Novel Technologies and Therapeutic Use

  • Editors: G. Subramanian

  • DOI: https://doi.org/10.1007/978-1-4419-8877-5

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 2004

  • Hardcover ISBN: 978-0-306-48315-8Published: 31 March 2004

  • Softcover ISBN: 978-1-4613-4702-6Published: 05 November 2012

  • eBook ISBN: 978-1-4419-8877-5Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XVI, 232

  • Topics: Pharmacy, Immunology, Pharmacology/Toxicology, Biomedical Engineering and Bioengineering

Publish with us

Policies and ethics

Back to top

Search

Navigation